| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1039247S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0139247 |
| P932 | PMC publication ID | 4605789 |
| P698 | PubMed publication ID | 26465152 |
| P5875 | ResearchGate publication ID | 283240298 |
| P2093 | author name string | Andre C Kalil | |
| Diana F Florescu | |||
| Lucile E Wrenshall | |||
| R Brian Stevens | |||
| Kirk W Foster | |||
| Clifford D Miles | |||
| John P Sandoz | |||
| Theodore H Rigley | |||
| Tamer Malik | |||
| P2860 | cites work | Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials | Q26823281 |
| Selection of induction therapy in kidney transplantation | Q26864234 | ||
| A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients | Q27000107 | ||
| Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program | Q28285436 | ||
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. | Q34181871 | ||
| Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature | Q34297088 | ||
| Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath | Q34304820 | ||
| Cyclosporin A in patients receiving renal allografts from cadaver donors | Q34347891 | ||
| Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. | Q34412887 | ||
| Albuminuria after renal transplantation: maintenance with sirolimus/low-dose tacrolimus vs. mycophenolate mofetil/high-dose tacrolimus | Q82457919 | ||
| Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients | Q82652142 | ||
| Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial | Q83059944 | ||
| Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys | Q83387311 | ||
| Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts | Q84139761 | ||
| De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure | Q84752864 | ||
| The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy | Q84758677 | ||
| Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
| Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation | Q47784519 | ||
| Graft survival after renal transplantation: Agenda for analysis | Q50170819 | ||
| Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study | Q56908066 | ||
| Late Calcineurin Inhibitor Withdrawal Prevents Progressive Left Ventricular Diastolic Dysfunction in Renal Transplant Recipients | Q57789840 | ||
| A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation | Q70277015 | ||
| Improved graft survival after renal transplantation in the United States, 1988 to 1996 | Q73502580 | ||
| Protocol biopsies should be part of the routine management of kidney transplant recipients. Con | Q77223327 | ||
| A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients | Q77378215 | ||
| Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation | Q77724954 | ||
| Analysis of HLA class I specific antibodies in patients with failed allografts | Q79552590 | ||
| Long-term results of rabbit antithymocyte globulin and basiliximab induction | Q79612858 | ||
| Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 | ||
| Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety | Q80602943 | ||
| Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology | Q80783273 | ||
| Is it safe to withdraw steroids within seven days of renal transplantation? | Q34448543 | ||
| Rabbit antithymocyte globulin versus basiliximab in renal transplantation | Q34580374 | ||
| A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes | Q34796915 | ||
| Calcineurin inhibitor nephrotoxicity | Q34945314 | ||
| Chronic renal allograft dysfunction | Q36240051 | ||
| Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence | Q36653136 | ||
| Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. | Q36752004 | ||
| Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. | Q37064446 | ||
| Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients | Q37164604 | ||
| Minimization of steroids in kidney transplantation | Q37228814 | ||
| Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival | Q37315152 | ||
| Minimizing the risk of chronic allograft nephropathy | Q37454291 | ||
| Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology | Q37731525 | ||
| Steroid minimization for sirolimus-treated renal transplant recipients | Q37760246 | ||
| Optimal immunosuppression to prevent chronic allograft dysfunction | Q37813415 | ||
| Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice | Q37907391 | ||
| Tolerogenic immunosuppression for organ transplantation | Q41116219 | ||
| Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure | Q42171636 | ||
| Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial | Q42466678 | ||
| Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study. | Q42620122 | ||
| Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience | Q43128472 | ||
| Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report | Q43412247 | ||
| Single-dose rATG induction at renal transplantation: superior renal function and glucoregulation with less hypomagnesemia. | Q43485090 | ||
| Chronic calcineurin inhibitor nephrotoxicity-lest we forget | Q43759235 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate | Q43973123 | ||
| A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). | Q44247085 | ||
| Steroid avoidance or withdrawal in renal transplantation. | Q44441917 | ||
| Improved scoring system to assess adult donors for cadaver renal transplantation | Q44461487 | ||
| The natural history of chronic allograft nephropathy | Q44688416 | ||
| A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy | Q44804127 | ||
| Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function | Q44966402 | ||
| Long-term immunosuppression, without maintenance prednisone, after kidney transplantation | Q45023761 | ||
| Improved long-term survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: a single centre experience. | Q45915544 | ||
| Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors. | Q45951672 | ||
| Transplantation: To convert or not to convert: lessons from the CONVERT trial. | Q45952176 | ||
| Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. | Q46007205 | ||
| Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial | Q46155747 | ||
| Modern approaches to combining sirolimus with calcineurin inhibitors | Q46187428 | ||
| Long-term deterioration of kidney allograft function | Q46485576 | ||
| A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis | Q46485598 | ||
| Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters | Q46512737 | ||
| Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus | Q46645995 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunosuppression | Q1455316 |
| P304 | page(s) | e0139247 | |
| P577 | publication date | 2015-10-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology | |
| P478 | volume | 10 |
| Q40125813 | A Double-Blind, Double-Dummy, Flexible-Design Randomized Multicenter Trial: Early Safety of Single- Versus Divided-Dose Rabbit Anti-Thymocyte Globulin Induction in Renal Transplantation |
| Q30239091 | Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. |
| Q49724077 | Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation |
Search more.